|
|||||||||||||||||||||||||
|
TuesdayStudy Reveals Investigational 24-Hour Formulation of Ropinirole Hcl Tablets Reduced "Off" Time for Patients With Parkinson's Disease
Failed to open page
The addition of investigational Requip® (ropinirole HCl) extended-release tablets to Parkinson's patients existing therapy delayed "off" time -- a well-known phenomenon in which symptoms return as patients' medication wears off -- by an average of more than two hours per day when compared to placebo, according to new data presented today at the annual European Federation of Neurological Societies Congress..... |
||||||||||||||||||||||||